CANCER NANOTHERANOSTICS: A NEW PARADIGM OF SIMULTANEOUS DIAGNOSIS AND THERAPY

Authors

  • Berihun Sisay Department of Pharmacy, College of Health Sciences, Mekelle University, P. O. Box 1871, Mekelle, Ethiopia.
  • Solomon Abrha Department of Pharmacy, College of Health Sciences, Mekelle University, P. O. Box 1871, Mekelle, Ethiopia.
  • Zewdu Yilma Department of Pharmacy, College of Health Sciences, Mekelle University, P. O. Box 1871, Mekelle, Ethiopia.
  • Admassu Assen
  • Fantahun Molla
  • Ebisa Tadese
  • Abrham Wondimu
  • Naod Gebre-Samuel
  • Gurudutta Pattnaik

Abstract

Despite  improvements  in  our  understanding  of cancer  and  the  emerging  concept  of personalized medicine for the treatment of this disease, it is still one of the leading causes of death worldwide. Although, in recent years, significant advances have been achieved in cancer therapy, many tumors are still challenging to treat and novel strategies are required to effectively combat this deadly disease. Nanotheranostics is a burgeoning field which makes use of nanotechnology for diagnosis and therapy of cancer. The recent advancement in the area of nanotechnology has enabled a new generation of different types of nanomaterials composed of either inorganic or polymer based nanoparticles to be useful for nanotheranostics applications such as to diagnose and treat diseases and monitoring the therapeutic response in vivo at molecular level; to enhance the control, evaluation and optimization of drug delivery and release; to target the drug by conjugating theranostic nanoplatformes with biological ligands. This review, therefore, summarizes the various nanocarriers developed so far for the simultaneous imaging and therapy, strategies for their targeted delivery, their potential applications and the challenges in their development and application for cancer therapy.

 

Key words: Cancer; Cancer therapy; Nanoparticles; Nanotheranostics.

DOI

https://doi.org/10.22270/jddt.v4i5.967

Published

2014-09-14
Statistics
Abstract Display: 897
PDF Downloads: 824

How to Cite

1.
Sisay B, Abrha S, Yilma Z, Assen A, Molla F, Tadese E, et al. CANCER NANOTHERANOSTICS: A NEW PARADIGM OF SIMULTANEOUS DIAGNOSIS AND THERAPY. J. Drug Delivery Ther. [Internet]. 2014 Sep. 14 [cited 2026 Jan. 22];4(5):79-86. Available from: https://jddtonline.info/index.php/jddt/article/view/967

Issue

Vol. 4 No. 5 (2014): Volume 4, Issue 5, Sep-Oct, 2014

Section

Review

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Sisay B, Abrha S, Yilma Z, Assen A, Molla F, Tadese E, et al. CANCER NANOTHERANOSTICS: A NEW PARADIGM OF SIMULTANEOUS DIAGNOSIS AND THERAPY. J. Drug Delivery Ther. [Internet]. 2014 Sep. 14 [cited 2026 Jan. 22];4(5):79-86. Available from: https://jddtonline.info/index.php/jddt/article/view/967
Crossref
Scopus
Google Scholar
Europe PMC